亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)加替沙星原料生產(chǎn)廠家供應(yīng)

 
 
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
品牌 武漢大華
過期 長期有效
更新 2012-10-23 14:32
 

武漢大華偉業(yè)醫(yī)藥化工公司

企業(yè)會員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

加替沙星
產(chǎn)品類別: 醫(yī)藥原料和中間體
產(chǎn)品含量: 99%
化學(xué)式: --
CAS編號: 180200-66-2

質(zhì)量標(biāo)準(zhǔn):CP2010
質(zhì)量標(biāo)準(zhǔn): 企業(yè)標(biāo)準(zhǔn)
包裝規(guī)格: 25KG紙板桶
產(chǎn)品說明: 產(chǎn)品名稱 加替沙星
質(zhì)量標(biāo)準(zhǔn) 企業(yè)標(biāo)準(zhǔn)
外觀性狀 白色或淡黃色粉末
含量 ≥98.5%(%)
重金屬 ≤0.002%(ppm)
英文名稱:Gatifloxacin 物理性質(zhì):本品為類白色或淺黃色結(jié)晶性粉末,溶于水、甲醇。 主要用途:醫(yī)藥原料中間體

舉報(bào)收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)氨茶堿原料廠家供應(yīng) 供應(yīng)溶菌酶原料藥廠家供應(yīng) 供應(yīng)磺胺嘧啶銀原料藥廠家供應(yīng) 供應(yīng)鹽酸苯海拉明原料藥廠家供應(yīng) 供應(yīng)L-鳥氨酸鹽酸鹽廠家供應(yīng) 供應(yīng)四磷酸腺二鳥苷原料藥-生產(chǎn)廠家供應(yīng) 供應(yīng)氯雷他定原料藥廠家供應(yīng) 供應(yīng)D-泛酸鈣廠家價(jià)格
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |